Chronic pain management should balance effective relief with strategies that reduce the risk of opioid addiction. multimodal care and opioid stewardship are central: combine nonpharmacologic therapies, non-opioid medications, careful patient selection, and clear monitoring. Evidence-based guidance in this area is summarized by Deborah Dowell Centers for Disease Control and Prevention, which emphasizes risk assessment, patient education, and use of alternatives before initiating long-term opioid therapy. Clinical decisions must reflect individual needs, comorbidities, and social context.
Risk assessment and informed initiation
shared decision-making and documented informed consent reduce misunderstandings and help patients weigh trade-offs between pain relief and addiction risk.
Non-opioid and nonpharmacologic alternatives
First-line approaches often include physical rehabilitation, exercise, cognitive behavioral therapy, and certain non-opioid medications such as NSAIDs or SNRIs, which can lower reliance on opioids. Access to these therapies varies with geography and socioeconomic status; rural communities and underserved populations may face barriers that increase opioid exposure. Multidisciplinary pain programs integrate physical, psychological, and social interventions and are associated with improved function and reduced reliance on long-term opioids.
Monitoring, mitigation, and response systems are essential. Regular assessments of function and pain, urine drug testing when indicated, checking prescription drug monitoring databases, and co-prescribing naloxone for high-risk patients help prevent adverse outcomes. If opioid therapy is ongoing, use the lowest effective dose, reassess frequently, and consider tapering when risks outweigh benefits. When opioid use disorder develops, evidence-based treatments such as buprenorphine or methadone combined with psychosocial support are effective and should be offered without delay.
Consequences of poor management extend beyond individual harm to families and communities through overdose, diversion, and social disruption. Cultural factors shape help-seeking and stigma; clinicians should provide culturally competent care and consider community resources. Minimizing addiction risk requires system-level support for alternatives, clinician training, equitable access, and patient-centered communication, grounded in the best available evidence.